FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381617070> ?p ?o ?g. }

• W4381617070 endingPage "3275" @default.
• W4381617070 startingPage "3275" @default.
• W4381617070 abstract "High stromal tumor-infiltrating lymphocytes (sTILs) are associated with improved pathologic complete response (pCR) in triple-negative breast cancer (TNBC). We hypothesize that integrating high sTILs and additional clinicopathologic features associated with pCR could enhance our ability to predict the group of patients on whom treatment de-escalation strategies could be tested. In this prospective early-stage TNBC neoadjuvant chemotherapy study, pretreatment biopsies from 408 patients were evaluated for their clinical and demographic features, as well as biomarkers including sTILs, Ki-67, PD-L1 and androgen receptor. Multivariate logistic regression models were developed to generate a computed response score to predict pCR. The pCR rate for the entire cohort was 41%. Recursive partitioning analysis identified ≥20% as the optimal cutoff for sTILs to denote 35% (143/408) of patients as having high sTILs, with a pCR rate of 59%, and 65% (265/408) of patients as having low sTILs, with a pCR rate of 31%. High Ki-67 (cutoff > 35%) was identified as the only predictor of pCR in addition to sTILs in the training set. This finding was verified in the testing set, where the highest computed response score encompassing both high sTILa and high Ki-67 predicted a pCR rate of 65%. Integrating Ki67 and sTIL may refine the selection of early stage TNBC patients for neoadjuvant clinical trials evaluating de-escalation strategies." @default.
• W4381617070 created "2023-06-23" @default.
• W4381617070 creator A5001315712 @default.
• W4381617070 creator A5001622762 @default.
• W4381617070 creator A5003107322 @default.
• W4381617070 creator A5009582590 @default.
• W4381617070 creator A5013934813 @default.
• W4381617070 creator A5014531785 @default.
• W4381617070 creator A5014713051 @default.
• W4381617070 creator A5017133246 @default.
• W4381617070 creator A5018129304 @default.
• W4381617070 creator A5023674071 @default.
• W4381617070 creator A5027764647 @default.
• W4381617070 creator A5027846283 @default.
• W4381617070 creator A5029062544 @default.
• W4381617070 creator A5029807055 @default.
• W4381617070 creator A5034373609 @default.
• W4381617070 creator A5041098535 @default.
• W4381617070 creator A5042271475 @default.
• W4381617070 creator A5047086634 @default.
• W4381617070 creator A5049701463 @default.
• W4381617070 creator A5053119598 @default.
• W4381617070 creator A5053893309 @default.
• W4381617070 creator A5055141762 @default.
• W4381617070 creator A5056566030 @default.
• W4381617070 creator A5071402753 @default.
• W4381617070 creator A5076145051 @default.
• W4381617070 creator A5077026571 @default.
• W4381617070 creator A5080832682 @default.
• W4381617070 creator A5087421367 @default.
• W4381617070 creator A5088814426 @default.
• W4381617070 creator A5092234157 @default.
• W4381617070 date "2023-06-21" @default.
• W4381617070 modified "2023-09-26" @default.
• W4381617070 title "Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial" @default.
• W4381617070 cites W1974685860 @default.
• W4381617070 cites W1975401903 @default.
• W4381617070 cites W2096145980 @default.
• W4381617070 cites W2096745115 @default.
• W4381617070 cites W2113479349 @default.
• W4381617070 cites W2118605519 @default.
• W4381617070 cites W2120431466 @default.
• W4381617070 cites W2149495821 @default.
• W4381617070 cites W2220948217 @default.
• W4381617070 cites W2430731787 @default.
• W4381617070 cites W2573889804 @default.
• W4381617070 cites W2585697071 @default.
• W4381617070 cites W2611463405 @default.
• W4381617070 cites W2748217064 @default.
• W4381617070 cites W2762153201 @default.
• W4381617070 cites W2766985996 @default.
• W4381617070 cites W2771978163 @default.
• W4381617070 cites W2774580734 @default.
• W4381617070 cites W2794819784 @default.
• W4381617070 cites W2797726290 @default.
• W4381617070 cites W2805197306 @default.
• W4381617070 cites W2806209829 @default.
• W4381617070 cites W2889003121 @default.
• W4381617070 cites W2909799373 @default.
• W4381617070 cites W2919605631 @default.
• W4381617070 cites W2946918907 @default.
• W4381617070 cites W2948415581 @default.
• W4381617070 cites W2979547848 @default.
• W4381617070 cites W2999400187 @default.
• W4381617070 cites W3006930853 @default.
• W4381617070 cites W3009233496 @default.
• W4381617070 cites W3087429828 @default.
• W4381617070 cites W3179860179 @default.
• W4381617070 cites W4205542251 @default.
• W4381617070 cites W4221046063 @default.
• W4381617070 cites W4224441465 @default.
• W4381617070 cites W4249751528 @default.
• W4381617070 cites W4293103127 @default.
• W4381617070 cites W4319158656 @default.
• W4381617070 doi "https://doi.org/10.3390/cancers15133275" @default.
• W4381617070 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37444385" @default.
• W4381617070 hasPublicationYear "2023" @default.
• W4381617070 type Work @default.
• W4381617070 citedByCount "0" @default.
• W4381617070 crossrefType "journal-article" @default.
• W4381617070 hasAuthorship W4381617070A5001315712 @default.
• W4381617070 hasAuthorship W4381617070A5001622762 @default.
• W4381617070 hasAuthorship W4381617070A5003107322 @default.
• W4381617070 hasAuthorship W4381617070A5009582590 @default.
• W4381617070 hasAuthorship W4381617070A5013934813 @default.
• W4381617070 hasAuthorship W4381617070A5014531785 @default.
• W4381617070 hasAuthorship W4381617070A5014713051 @default.
• W4381617070 hasAuthorship W4381617070A5017133246 @default.
• W4381617070 hasAuthorship W4381617070A5018129304 @default.
• W4381617070 hasAuthorship W4381617070A5023674071 @default.
• W4381617070 hasAuthorship W4381617070A5027764647 @default.
• W4381617070 hasAuthorship W4381617070A5027846283 @default.
• W4381617070 hasAuthorship W4381617070A5029062544 @default.
• W4381617070 hasAuthorship W4381617070A5029807055 @default.
• W4381617070 hasAuthorship W4381617070A5034373609 @default.
• W4381617070 hasAuthorship W4381617070A5041098535 @default.
• W4381617070 hasAuthorship W4381617070A5042271475 @default.
• W4381617070 hasAuthorship W4381617070A5047086634 @default.

• next